Q4 FY26 earnings results
Jan–Mar 2026 quarter · revenue and profit against the same quarter last year (YoY) and the quarter before (QoQ). INR crore, consolidated where filed.
385 companies have reported Jan–Mar 2026 and 936 more have a results date ahead. 72% grew profit from a year ago; the typical company's sales grew +13.5% and profit +21.2%. Strongest sector: Consumer Durables (+61.1%); weakest: Healthcare (-26.9%).
Declared
385/ 1321
29% of scheduled reporters
Profit breadth
72%/28%
grew / declined · 337 comparable
Median sales growth
+13.5%
year on year, all reporters
Median profit growth
+21.2%
year on year, all reporters
Operating margin
219/149
expanded / shrank vs a year ago
Strongest / weakest
Consumer Durables +61.1%
Healthcare -26.9%
median profit growth, 5+ reporters
1–9 of 9
| Company | Revenue (₹ Cr) | Net profit (₹ Cr) | Per share | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Sector | Reported | YoY | QoQ | Reported | YoY | QoQ | EPS (₹) | Verdict | 8Q profit |
| DRREDDYDr. Reddy's Laboratories Limited | Healthcare | 7,546 | -11.5% | -13.8% | 221 | -86.1% | -81.4% | 2.65 | Shrinking | |
| CIPLACipla Limited | Healthcare | 6,541 | -2.8% | -7.5% | 543 | -55.3% | -19.4% | 6.87 | Shrinking | |
| TORNTPHARMTorrent Pharmaceuticals Limited | Healthcare | 4,197 | +41.8% | +27.1% | 364 | -26.9% | -42.7% | 10.76 | Mixed | |
| MANKINDMankind Pharma Limited | Healthcare | 3,443 | +11.8% | -3.5% | 559 | +31.5% | +35.0% | 13.43 | Growing | |
| SYNGENESyngene International Limited | Healthcare | 1,036 | +1.8% | +13.0% | 148 | -19.1% | +886.7% | 3.67 | Mixed | |
| ERISEris Lifesciences Limited | Healthcare | 757 | +7.4% | -6.2% | 279 | +173.5% | +156.0% | 20.33 | Growing | |
| ACUTAASAcutaas Chemicals Limited | Healthcare | 433 | +40.6% | +10.2% | 134 | +112.7% | +26.4% | 16.09 | Growing | |
| ONESOURCEOnesource Specialty Pharma Limited | Healthcare | 428 | +0.5% | +47.6% | 5 | -94.9% | n/a | 0.40 | Mixed | |
| CONCORDBIOConcord Biotech Limited | Healthcare | 326 | -24.2% | +17.3% | 90 | -36.6% | +32.4% | 8.60 | Shrinking | |
Verdict: Growing sales and profit both up on a year ago · Shrinking both down · Mixed one up, one down · Back to profit a profit after a loss a year ago · Loss a loss this quarter. "n/a" means a year-ago or previous figure isn't available, or it was a loss, so a percentage would mislead.